Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve the health and well-being of patients in this community. Dova is a wholly-owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi).